Up-Regulated Expression of Calcium Dependent Annexin A6: A Potential Biomarker of Ovarian Carcinoma.
An early and accurate diagnosis of ovarian carcinoma (OC) is likely to reduce morbidity and mortality of the patients. To improve the clinical outcome in OC patients, present study is aimed to identify robust biomarkers for early OC diagnosis and prognosis. In order to look for early-stage protein markers, a systematic protein profiling approach involving 2-dimensional gel electrophoresis coupled with MALDI-TOF MS analyses of human malignant and non-malignant ovarian biopsy samples and analysis of the data by using relevant software was performed in this study. Six 2D-gel spots, corresponding to five proteins, displayed statistically significant differential expression in the tumor tissues in comparison with the non-malignant tissues [FDR ≤0.05; PMF score ≥79]. In silico pathway studies by IPA predicted two proteins i.e., Ca2+ dependent membrane-binding protein annexin A6 (AnxA6) and the metabolic enzyme L-lactate dehydrogenase A chain, as potential predictive biomarkers. Increased expression of AnxA6 was further ascertained by Western blot and ELISA analysis in the resected tissues and the plasma of the subjects. The expression was found markedly increased particularly in the advanced stage tumors. The significant up-regulation of AnxA6 in OC, reported for the first time, is likely to provide insight into the mechanism of OC progression, which may lead to the design of potential diagnostic and therapeutic strategies. This article is protected by copyright. All rights reserved.